WCLC 2026 Patient Advocate Takeover: Centering Patient Voices in Research and Care
Lung Cancer ConsideredShow Notes
In this special Patient Advocate Takeover episode, recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, patient advocates Dr. Sydney Barned and Yvonne Diaz discuss the research and conversations that caught their attention at the meeting.
They reflect on access to new therapies, the importance of involving patient advocates early in clinical trial design, and how stronger communication between patients and providers can improve care. Plus, hear what they look for in new research and their perspectives on topics such as survivorship research and exercise oncology.
Guests: Dr. Sydney Barned Physician and Patient Advocate Living with Stage IV ALK-positive lung cancer
Yvonne Diaz Co-founder and Chair, Oncogene Cancer Research Board Member, ALK Positive Inc.
More from Lung Cancer Considered
The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages.
The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages.
The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages.
Recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, this special Early Career Takeover episode explores what this annual meeting offers to researchers and clinicians at the start of their careers.
The WHO Eastern Mediterranean Region (EMRO) faces unique challenges around exposures, non-conventional smoking, lung cancer screening, molecular profiling, and evolving therapies in lung cancer. To address this, the inaugural joint IASLC/EMRO workshop took place at the 2026 World Conference on Lung Cancer (WCLC) in Seoul.